Determinants of visual acuity outcomes in eyes with neovascular AMD treated with anti-VEGF agents: an instrumental variable analysis of the AURA study

PURPOSE: To identify the strongest variable(s) linked with the number of ranibizumab injections and outcomes in AURA, and to identify ways to improve outcomes using this association. METHODS: AURA was a large observational study that monitored visual acuity over a 2-year period in patients with neov...

Descripción completa

Detalles Bibliográficos
Autores principales: Holz, F G, Tadayoni, R, Beatty, S, Berger, A R, Cereda, M G, Hykin, P, Staurenghi, G, Wittrup-Jensen, K, Nilsson, J, Kim, K, Sivaprasad, S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985685/
https://www.ncbi.nlm.nih.gov/pubmed/27197868
http://dx.doi.org/10.1038/eye.2016.90

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4985685/
https://www.ncbi.nlm.nih.gov/pubmed/27197868
http://dx.doi.org/10.1038/eye.2016.90

Ejemplares similares